NYSE · Industrials
ACCENDRA HEALTH INC/VA/ (ACH)
As-reported financials and recent SEC filings for ACCENDRA HEALTH INC/VA/, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.76B
Net income
$-1.10B
Net margin
-39.8%
Diluted EPS
$-14.31
ROE
238.8%
P/E (TTM)
—
Market cap
$255.8M
Debt / equity
-3.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.76B | $2.68B | $2.55B | $9.96B | $9.79B |
| Gross profit | $1.29B | $1.28B | $1.22B | $1.83B | $1.51B |
| Operating income | $27.5M | $-217.7M | $133.2M | $142.9M | $368.5M |
| Net income | $-1.10B | $-362.7M | $-41.3M | $22.4M | $221.6M |
| Diluted EPS | $-14.31 | $-4.73 | $-0.53 | $0.29 | $2.94 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-25
View on EDGAR →8-K2026-06-15
View on EDGAR →SD2026-05-29
View on EDGAR →8-K2026-05-22
View on EDGAR →42026-05-20
View on EDGAR →42026-05-19
View on EDGAR →42026-05-19
View on EDGAR →42026-05-19
View on EDGAR →Go deeper on ACH
Search ACCENDRA HEALTH INC/VA/’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.